The American Journal of Managed Care19h
With Sub-Q Immunotherapy Coming, “Patient Preference Has to Be the Key”
An oncologist from Atrium Health outlines how saving time administering immunotherapy could have far-reaching benefits.
Clinical Trials Arena on MSN16d
J&J’s fully subcutaneous Tremfya shows 27.6% clinical remission in UC
Tremfya was administered subcutaneously for both induction and maintenance, inducing a clinical response in 65% of moderate to severe UC patients.
Medscape10d
Subcutaneous Guselkumab Proves Efficacious for IBD in Two Studies: ASTRO and GRAVITI
For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...
Arrowhead Pharmaceuticals Announces Topline Results from Part 2 of Phase 1/2 Study of ARO-C3 in Patients with IgA Nephropathy
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced topline results from Part 2 of a Phase 1/2 clinical study of ARO-C3, the company’s investigational RNA interference (RNAi) therapeutic ...
Fierce Pharma3d
In patent clash over injectable Keytruda, Merck and Halozyme dig in for a fight
Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma ...
Study Finds on MSN3d
When it comes to weight loss, the type of belly fat you shed matters most
Understand the complexities of fat loss. Fat distribution plays a crucial role in health risks connected to visceral fat.
Knowridge Science Report1d
Why deep belly fat is the key to successful weight loss
Not all body fat is the same when it comes to health and weight loss. Fat that sits just under the skin, called subcutaneous ...
PipelineReview.com1h
CagriSema demonstrates superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial
BAGSVAERD, Denmark I March 10, 2025 I Today, Novo Nordisk announced headline results from REDEFINE 2, a phase 3 trial in the global REDEFINE programme.
HEALTH AND FITNESS: Why body fat matters for health
Everyone knows that fat is where the extra calories you eat end up and the main reason your clothes fit too tightly. Body fat ...
Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial
Novo Nordisk announced headline results from REDEFINE 2, a phase 3 trial in the global REDEFINE programme. REDEFINE 2 is a 68 ...